Literature DB >> 20807805

Survivin enhances motility of melanoma cells by supporting Akt activation and {alpha}5 integrin upregulation.

Jodi A McKenzie1, Tong Liu, Agnessa G Goodson, Douglas Grossman.   

Abstract

Survivin expression in melanoma is inversely correlated with patient survival. Transgenic mice harboring melanocyte-specific overexpression of survivin exhibit increased susceptibility to UV-induced melanoma and metastatic progression. To understand the mechanistic basis for metastatic progression, we investigated the effects of survivin on the motility of human melanocytes and melanoma cells. We found that survivin overexpression enhanced migration on fibronectin and invasion through Matrigel, whereas survivin knockdown under subapoptotic conditions blocked migration and invasion. In melanocytes, survivin overexpression activated the Akt and mitogen-activated protein kinase pathways. Akt phosphorylation was required for survivin-enhanced migration and invasion, whereas Erk phosphorylation was required only for enhanced invasion. In both melanocytes and melanoma cells, survivin overexpression was associated with upregulation of α5 integrin (fibronectin receptor component), the antibody-mediated blockade or RNA interference-mediated knockdown of which blocked survivin-enhanced migration. Knockdown of α5 integrin did not affect Akt activation, but inhibition of Akt phosphorylation prevented α5 integrin upregulation elicited by survivin overexpression. Together, our results showed that survivin enhanced the migration and invasion of melanocytic cells and suggested that survivin may promote melanoma metastasis by supporting Akt-dependent upregulation of α5 integrin. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807805      PMCID: PMC2955769          DOI: 10.1158/0008-5472.CAN-10-0194

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

1.  Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis.

Authors:  Marzia Pennati; Gennaro Colella; Marco Folini; Lorenzo Citti; Maria Grazia Daidone; Nadia Zaffaroni
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 2.  Get a ligand, get a life: integrins, signaling and cell survival.

Authors:  Dwayne G Stupack; David A Cheresh
Journal:  J Cell Sci       Date:  2002-10-01       Impact factor: 5.285

3.  Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.

Authors:  D Grossman; J M McNiff; F Li; D C Altieri
Journal:  J Invest Dermatol       Date:  1999-12       Impact factor: 8.551

4.  Mitogen-actived protein kinase activation is an early event in melanoma progression.

Authors:  Cynthia Cohen; Angel Zavala-Pompa; Judy H Sequeira; Mamoru Shoji; Deborah G Sexton; George Cotsonis; Francesca Cerimele; Baskaran Govindarajan; Nada Macaron; Jack L Arbiser
Journal:  Clin Cancer Res       Date:  2002-12       Impact factor: 12.531

5.  Cancer gene therapy using a survivin mutant adenovirus.

Authors:  M Mesri; N R Wall; J Li; R W Kim; D C Altieri
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

6.  Apoptosis regulators and responses in human melanocytic and keratinocytic cells.

Authors:  Anneli R Bowen; Adrianne N Hanks; Sarah M Allen; April Alexander; Miyoung J Diedrich; Douglas Grossman
Journal:  J Invest Dermatol       Date:  2003-01       Impact factor: 8.551

7.  JWA regulates melanoma metastasis by integrin alphaVbeta3 signaling.

Authors:  J Bai; J Zhang; J Wu; L Shen; J Zeng; J Ding; Y Wu; Z Gong; A Li; S Xu; J Zhou; G Li
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

8.  Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.

Authors:  Sarah M Allen; Scott R Florell; Adrianne N Hanks; April Alexander; Miyoung J Diedrich; Dario C Altieri; Douglas Grossman
Journal:  Cancer Res       Date:  2003-02-01       Impact factor: 12.701

9.  Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.

Authors:  Angela Gradilone; Paola Gazzaniga; Diego Ribuffo; Susanna Scarpa; Emanuele Cigna; Fortunata Vasaturo; Ugo Bottoni; Daniele Innocenzi; Stefano Calvieri; Nicolo' Scuderi; Luigi Frati; Anna Maria Aglianò
Journal:  J Clin Oncol       Date:  2003-01-15       Impact factor: 44.544

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

View more
  29 in total

1.  1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitates curcumin-induced melanoma cell apoptosis by enhancing ceramide accumulation, JNK activation, and inhibiting PI3K/AKT activation.

Authors:  Teng Yu; Jinchao Li; Ying Qiu; Hui Sun
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

2.  Phosphorylation of membrane type 1-matrix metalloproteinase (MT1-MMP) and its vesicle-associated membrane protein 7 (VAMP7)-dependent trafficking facilitate cell invasion and migration.

Authors:  Karla C Williams; Marc G Coppolino
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

3.  Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma.

Authors:  G Renner; H Janouskova; F Noulet; V Koenig; E Guerin; S Bär; J Nuesch; F Rechenmacher; S Neubauer; H Kessler; A-F Blandin; L Choulier; N Etienne-Selloum; M Lehmann; I Lelong-Rebel; S Martin; M Dontenwill
Journal:  Cell Death Differ       Date:  2015-10-16       Impact factor: 15.828

4.  An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in Melanoma.

Authors:  Jessica L F Teh; Timothy J Purwin; Evan J Greenawalt; Inna Chervoneva; Allison Goldberg; Michael A Davies; Andrew E Aplin
Journal:  Cancer Res       Date:  2016-08-03       Impact factor: 12.701

Review 5.  Ceramide-orchestrated signalling in cancer cells.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

6.  RNA interference-mediated survivin gene knockdown induces growth arrest and reduced migration of vascular smooth muscle cells.

Authors:  Christoph S Nabzdyk; Hope Lancero; Khanh P Nguyen; Sherveen Salek; Michael S Conte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

7.  Immunohistochemical expression and serum level of survivin protein in colorectal cancer patients.

Authors:  Katarzyna Jakubowska; Anna Pryczynicz; Violetta Dymicka-Piekarska; Waldemar Famulski; Katarzyna Guzińska-Ustymowicz
Journal:  Oncol Lett       Date:  2016-09-01       Impact factor: 2.967

8.  Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity.

Authors:  Arash Latifkar; Lu Ling; Amrit Hingorani; Eric Johansen; Amdiel Clement; Xiaoyu Zhang; John Hartman; Claudia Fischbach; Hening Lin; Richard A Cerione; Marc A Antonyak
Journal:  Dev Cell       Date:  2019-04-11       Impact factor: 12.270

Review 9.  Survivin - The inconvenient IAP.

Authors:  Dario C Altieri
Journal:  Semin Cell Dev Biol       Date:  2015-01-12       Impact factor: 7.727

10.  Survivin promotion of melanoma metastasis requires upregulation of α5 integrin.

Authors:  Jodi A McKenzie; Tong Liu; Jae Y Jung; Benjamin B Jones; Huseyin A Ekiz; Alana L Welm; Douglas Grossman
Journal:  Carcinogenesis       Date:  2013-05-02       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.